 |
|
|
|
|
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Mucke L. on PAPER: Cissé M. et al., 2011, I fully understand and share Dr. Strittmatter’s eagerness to resolve the controversy surrounding... 3 Aug 2011.
|
|
|
 |
|
|
Mucke L. on PAPER: Cissé M. et al., 2011, Reply to comment by Nikolaos K. Robakis
I much appreciate Nick’s comments, and fully... 17 Dec 2010.
|
|
|
|
|
|
Mucke L. on PAPER: Andrews-Zwilling Y. et al., 2010, By demonstrating a selective vulnerability of hilar interneurons to intracellularly generated... 18 Oct 2010.
|
|
|
|
|
|
Mucke L. on NEWS: Honolulu: The Missing Link? Tau Mediates Aβ Toxicity at Synapse, I am very enthusiastic about the paper by Ittner et al. for several reasons. First, it confirms... 26 Jul 2010.
|
|
|
|
|
|
Mucke L. on NEWS: Reelin, Aβ, α7 Play Yin and Yang Around NMDA Receptors, The results are very interesting and relate closely to findings we obtained in hAPP transgenic... 11 Sep 2009.
|
|
|
|
|
|
Mucke L. on NEWS: Lessons From the Lipidome—PLA2 Linked to AD Pathology, Comment by Rene Sanchez-Mejia and Lennart Mucke
We thank Tom Fagan, Tobias Hartmann,... 6 Nov 2008.
|
|
|
|
|
|
Mucke L, Palop J. on NEWS: Do "Silent" Seizures Cause Network Dysfunction in AD?, Comment by Jorge J. Palop and Lennart Mucke
We completely agree with Dr. Ashford in... 14 Sep 2007.
|
|
|
|
|
|
Mucke L. on NEWS: Enhancing Aβ Fibrillization Boosts Mouse Memory, I appreciate Drs. Iijima and Iijima-Ando’s comments on our paper and would like to address a... 30 Aug 2007.
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
